Sign in

Jon Salmanton-García

@salmantongarcia.bsky.social
41 followers 22 following 74 posts

PostDoc @uniklinikkoeln.bsky.social and @cecad.bsky.social #FECMM ‪@efisg-escmid.bsky.social‬ Chair 2024-26 YoungEHA Committee member 2025- ‪@fungiscope.bsky.social‬ #VACCELERATE #EPICOVIDEHA #hematology #mycoses #ViralRespiratoryInfections

PostsRepliesMedia
Reposted by Jon Salmanton-García
ESCMID Fungal Infection Study Group (EFISG) @efisg-escmid.bsky.social · 29/09/2026
EFISG webinars 🍄 8 Oct: IFI at autopsy 13 Oct: Phaeohyphomycosis 28 Oct: Disseminated fusariosis 6 Nov: Water, fungi and health 17 Nov: Difficult & curious cases Links below 👇
us06web.zoom.us
Welcome! You are invited to join a webinar: EFISG & ESGFOR: Invasive Fungal Infections diagnosis at autopsy: cases and discussion. After registering, you will receive a confirmation email about joinin...
Chairs Jon Salmanton-García & Domitille Callon Speakers: Pediatric case – Forensic Point of view Domitille Callon Adult case – Microbiologist Point of view Jean-Pierre Gangneux Pathology diagn...
103
Jon Salmanton-García @salmantongarcia.bsky.social · 08/09/2026
🔬🇫🇷 How prepared is France for fungal infections? 📊 Survey of 50 centres: 🧪 98% access to susceptibility testing 🔍 98% MALDI-TOF for identification 💊 100% access to major antifungals 🚀 Strong national capacity www.sciencedirect.com/science/arti...
121
Jon Salmanton-García @salmantongarcia.bsky.social · 07/09/2026
Awareness of fungal disease is no longer the bottleneck. Action is. Major challenges remain in surveillance, diagnostics, clinical trials and specialist expertise... www.sciencedirect.com/science/arti...
sciencedirect.com
Emerging fungal infections and research gaps: Awareness is no longer the bottleneck
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
000
Jon Salmanton-García @salmantongarcia.bsky.social · 27/08/2026
🌍 17 webinars. 4,631 registrations. Participants from 128 countries. Our 2025 @efisg-escmid.bsky.social series shows the power of digital education to expand global access to expertise in medical mycology. 🍄📚 www.sciencedirect.com/science/arti...
112
Jon Salmanton-García @salmantongarcia.bsky.social · 11/08/2026
Fungal Infections collection in #BMCImmunology acceps submissions until 25.09.26; reviews welcome! Working on #antifungal_resistance, #novel_therapies, #dermatophytes, #nanotechnology, #host–pathogen_interactions, or related topics? 👉 link.springer.com/collections/...
link.springer.com
Fungal infections
Fungal infections significantly threaten human health, particularly in immunocompromised individuals. The spectrum of fungal infections ranges from ...
000
Jon Salmanton-García @salmantongarcia.bsky.social · 09/08/2026
Fungal diseases are often missed in #Africa, affecting diagnosis, treatment and AMR surveillance. Better fungal diagnostics and surveillance must be part of the AMR response. @thelancet.com www.thelancet.com/journals/lan...
thelancet.com
Invisible fungal disease, visible consequences: diagnostic capacity and antimicrobial resistance in Africa
Severe invasive fungal diseases (IFD) cause about 6.5 million infections and 3.8 million deaths every year,1 a burden similar to tuberculosis and malaria. However, IFD are largely missing from nationa...
032
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 31/07/2026
Thanks to the entire team! We've already supported many @ishamycology.bsky.social & #ECMM projects with our capacity for multinational collaborative research and we're always happy to support new collaborations. www.nature.com/articles/s41... @salmantongarcia.bsky.social @natcomms.nature.com
nature.com
Fungal diagnostics and antifungal drug access in Latin America and the Caribbean: an ESCMID EFISG multinational survey - Nature Communications
Here, in a survey of 619 institutions across Latin America and the Caribbean, the authors showcase major gaps in fungal diagnostics and antifungal access, with stark disparities linked to income and i...
044
Jon Salmanton-García @salmantongarcia.bsky.social · 29/07/2026
Less can be more 📊 The multicentre E-PEC trial shows a clear shift in #endometrial #cancer #surgery, with increasing use of sentinel lymph node procedures and fewer systematic lymphadenectomies, reflecting a move toward less invasive staging link.springer.com/article/10.1...
000
Jon Salmanton-García @salmantongarcia.bsky.social · 28/07/2026
Timely diagnosis of invasive mycoses saves lives 🦠 @efisg-escmid.bsky.social study reveals disparities in access to diagnostics and therapies across #LATAM #Caribbean, highlighting urgent need to strengthen laboratory capacity and improve access to essential drugs www.nature.com/articles/s41...
013
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 22/06/2026
@salmantongarcia.bsky.social represented our team at the #EHA2026 Congress in Stockholm, connecting with leading experts and exploring the latest developments in hematology. Great conversations, valuable insights, and new perspectives to bring back to our work. #Hematology #Healthcare
022
Jon Salmanton-García @salmantongarcia.bsky.social · 05/06/2026
🚨 Metapneumovirus (#hMPV) causes severe disease in hem_onc patients, with ICU admission and mortality rates comparable to influenza and COVID-19. Yet it remains largely overlooked. 🎥 Watch our @vumediid.bsky.social presentation based on the #EPICOVIDEHA registry: www.vumedi.com/video/human-...
vumedi.com
Human Metapneumovirus (hMPV) Outcomes in Patients With Hematologic Malignancies: Insights From the EPICOVIDEHA/EPIRESEHA Registry
A video from Jon Salmanton-García, posted on Jun 3, 2026.
000
Jon Salmanton-García @salmantongarcia.bsky.social · 25/05/2026
Seeing our research become one of the most read in @AjHematology is incredibly moving. This recognition belongs to the entire #EPICOVIDEHA-EPIRESEHA network! 🩺✨ Your interest gives true meaning to our scientific work. 🔗 onlinelibrary.wiley.com/doi/10.1002/... @olivercornely.bsky.social
022
Jon Salmanton-García @salmantongarcia.bsky.social · 18/05/2026
🚢🦠 @cmijournal.bsky.social on #Andes #hantavirus outbreak linked to #MVHondius Key reminder of how zoonoses, global travel, and confined settings can rapidly evolve into multinational public health challenges. #OneHealth #EmergingInfections www.clinicalmicrobiologyandinfection.org/article/S119...
clinicalmicrobiologyandinfection.org
Andes hantavirus outbreak on a cruise ship - an ESCMID Emerging Infections Subcommittee (EIS) rapid assessment
The ongoing cluster of hantavirus infections associated with the cruise ship MV Hondius represents an unusual but instructive event at the intersection of zoonotic spillover, human mobility, confined ...
000
Reposted by Jon Salmanton-García
ESCMID Fungal Infection Study Group (EFISG) @efisg-escmid.bsky.social · 28/04/2026
New #EFISG Board members 2026-2028 @salmantongarcia.bsky.social – Chair Riina Richardson – Treasurer Dionysios Neofytos– Secretary Claudia Bartalucci– Educational Officer Zoi Dorothea Pana – Scientific Officer @escmid.bsky.social
001
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 12/05/2026
Viral infections in immunocompromised patients remain an evolving clinical challenge. Key insights from #ESCMID2026 by @salmantongarcia.bsky.social on diagnostics, prophylaxis & antiviral management: touchinfectiousdiseases.com/insight/mana... #InfectiousDiseases #Immunocompromised
touchinfectiousdiseases.com
Managing viral infections in immunocompromised patients: Key clinical updates from ESCMID 2026 - touchINFECTIOUS DISEASES
At ESCMID 2026, Dr Jon Salmanton-Garcia (University of Cologne, Germany) discussed the growing challenge of viral infections in immunocompromised patients. He
023
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 18/05/2026
New publication in #MedicalMycology: “Profiling medical mycologists” by the #ESCMID #FungalInfection Study Group (#EFISG). Survey of 342 experts from 72 countries highlights the diversity, collaboration, and future needs. @salmantongarcia.bsky.social pubmed.ncbi.nlm.nih.gov/41995303/ #GlobalHealth
pubmed.ncbi.nlm.nih.gov
Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group (EFISG) - PubMed
Invasive fungal infections are a major cause of morbi-mortality, particularly in immunocompromised and critically ill patients. Increasing antifungal resistance, unequal access to diagnostics and ther...
034
Reposted by Jon Salmanton-García
ESCMID Fungal Infection Study Group (EFISG) @efisg-escmid.bsky.social · 24/04/2026
New accepted manuscript from hashtag #EFISG! 🌍🧫 “Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group” academic.oup.com/mmy/advance-...
academic.oup.com
Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group (EFISG)
Abstract. Invasive fungal infections (IFI) are a major cause of morbi-mortality, particularly in immunocompromised and critically ill patients. Increasing
001
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 20/04/2026
Proud of our team at #ESCMID in Munich! Two great posters today: Luise Hänsel on the 2025 EQUAL Pneumocystis Score & @salmantongarcia.bsky.social Salmanton-García on capacity for invasive fungal diseases in LATAM/Caribbean. Strong results, true team spirit! #Mycology #ID
182
Reposted by Jon Salmanton-García
ESCMID Fungal Infection Study Group (EFISG) @efisg-escmid.bsky.social · 14/04/2026
📢 𝐄𝐅𝐈𝐒𝐆 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 🗓 Monday, 20 April 2026 ⏰ 16:15–17:15 CET 📍 ICM 4 (ESCMID Global in Munich) + key4events.zoom.us/j/85290315683?pwd=ydbah1cboY2Z43NtobRMvZ3CEsGuDN.1 🎁 EFISG pins will be available, grab yours!
001
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 24/03/2026
@salmantongarcia.bsky.social from our team is at the EBMT Annual Meeting 2026 and excited to dive into the latest in cell therapy and transplantation. Looking forward to inspiring talks, new insights, and great conversations! 🚀 👉 Explore the programme: www.ebmt.org/annual-meeti...
011
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 24/03/2026
Insightful session at EBMT 2026: Dr. Jon Salmanton-García @salmantongarcia.bsky.social presenting on rare fungal infections after HSCT (Fusarium, Scedosporium). Important perspectives on managing complex infections in immunocompromised patients. #EBMT2026 #HSCT #InfectiousDiseases
173
Jon Salmanton-García @salmantongarcia.bsky.social · 16/03/2026
Fungi are levelling up and we aren't ready. 🍄⚠️ Climate change is eroding our "thermal shield," training fungi to survive human body heat. The stats: 💀 3.8M deaths/year 💊 Rising drug resistance 🌍 Rapid geographic spread Time for #OneHealth www.clinicalmicrobiologyandinfection.org/article/S119...
clinicalmicrobiologyandinfection.org
Emerging mycoses: a neglected area of concern for global health
One of the most neglected, yet rapidly developing, areas of concern in global health is the changing epidemiology of fungal infections.
020
Jon Salmanton-García @salmantongarcia.bsky.social · 10/03/2026
🦟 Dengue is not benign in immunocompromised patients #DANGO registry study from the 2023–2024 Argentina 🇦🇷 outbreak - 64% hospitalized - 90% thrombocytopenia - 6% mortality - Transfusion-associated cases Wake-up call for clinicians in endemic regions! onlinelibrary.wiley.com/doi/10.1111/...
000
Reposted by Jon Salmanton-García
ESCMID Fungal Infection Study Group (EFISG) @efisg-escmid.bsky.social · 09/03/2026
25 March 2026 at 08:00 CET Candida Endocarditis: when yeast meets the heart uni-koeln.zoom.us/meeting/regi...
001
Jon Salmanton-García @salmantongarcia.bsky.social · 10/03/2026
Honoured to be re-elected to the Executive Committee of the European Fungal Infection Study Group (2026–2028) within @escmid.bsky.social Thank you for the trust😊 Full election results: www.escmid.org/fileadmin/es...
escmid.org
000
Jon Salmanton-García @salmantongarcia.bsky.social · 04/03/2026
‪TDM in hematology... 🔎 209 physicians | 32 countries ✅ 97% access ✅ 71% adapt treatment ⏱ Faster turnaround = more action 🚀 Expanding to targeted therapies 💡 From classical monitoring to precision medicine. 📖 www.mjhid.org/mjhid/articl... @jannikstemler.bsky.social @olivercornely.bsky.social
mjhid.org
011
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 04/03/2026
🎥 New data on #hMPV in patients with hematologic malignancies: @salmantongarcia.bsky.social highlights how the lack of prophylaxis & treatment increases hospitalizations, ICU needs, and mortality. Watch now: youtu.be/1EsYHcRQZ8g Publication: doi.org/10.1093/ofid... #Hematology #InfectiousDiseases
youtu.be
hMPV in Hematologic Malignancies: Key Insights from EPICOVIDEHA/EPIRESEHA
YouTube video by IDIM IDIM
012
Jon Salmanton-García @salmantongarcia.bsky.social · 04/03/2026
youtu.be/1EsYHcRQZ8g?...
youtu.be
hMPV in Hematologic Malignancies: Key Insights from EPICOVIDEHA/EPIRESEHA
YouTube video by IDIM IDIM
000
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 03/03/2026
Mycological diagnostics in Australia & NZ vary widely. Key non-culture tests are often offsite, β-D-glucan access is rare, and antifungal resistance surveillance remains limited. Important gaps in regional capability. 🔗 www.sciencedirect.com/science/arti... #Mycology @salmantongarcia.bsky.social
sciencedirect.com
Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testing
Access to mycological diagnostics varies across clinical laboratories. This study aimed to assess the availability of key fungal diagnostic methods in…
001
Jon Salmanton-García @salmantongarcia.bsky.social · 03/03/2026
hMPV in haematological malignancy is serious 📊 130 pts 64% hospitalized 19% ICU 8% 30-day mortality ⚠️ Severity ≈ influenza & COVID-19 ❌ No vaccine ❌ No targeted treatment hMPV is not benign in immunocompromised patients We need awareness, prevention + therapies academic.oup.com/ofid/advance...
001
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 26/02/2026
🦠 EHA-SWG Infections in Hematology Webinar 📅 March 2, 2026 | 16:00 CET 🎤 @salmantongarcia.bsky.social Insights from the EPIAMLINF registry on infections in AML patients – epidemiology, outcomes & clinical impact. 👉 Register now! ehaweb-org.zoom.us/meeting/regi...
034
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 23/02/2026
Heute & morgen: Gemeinsame #DZIF/#PEG-Jahrestagung 2026 in Bonn 🦠🔬 Fokus auf Gender & Precision Medicine, AMR, Drug Development & Wirt-Erreger-Interaktionen. Unser Team ist heute mit 3 Postern vertreten @salmantongarcia.bsky.social! 💬🖼️ #InfectiousDiseases #AMR #Science
053
Jon Salmanton-García @salmantongarcia.bsky.social · 23/02/2026
Presented at the @dzif.bsky.social @DGI Annual Meeting 🇩🇪 🔎 P-I-21: Clinical features and outcomes of dengue in hematological malignancies 💊 P-I-22: Use of ceftazidime–avibactam in severe bacterial superinfections 🤝 Strong Argentine–German collaboration 🇦🇷🇩🇪
010
Reposted by Jon Salmanton-García
ESCMID Fungal Infection Study Group (EFISG) @efisg-escmid.bsky.social · 17/02/2026
Info for registered EFISG members: Voting for EFISG Board ('26–'28) is open until March 2nd To vote: Log in at my.escmid.org 🖱️“Study group elections” 🖱️“ESCMID Fungal Infection Study Group (EFISG) [Election open]” 🖱️“Vote ballot” 🖱️Candidate(s) and click “VOTE”
my.escmid.org
EAA
002
Jon Salmanton-García @salmantongarcia.bsky.social · 13/02/2026
Final call – 3 days left! We seek input on pediatric infectious diseases (PID) postgraduate training from Iceland🇮🇸 Liechtenstein🇱🇮 Lithuania🇱🇹 Montenegro🇲🇪 North Macedonia🇲🇰 United Kingdom🇬🇧 Even confirmation of no programme is valuable Please share: www.surveymonkey.com/r/FNW5GWV
surveymonkey.com
ESPID PID European Training Survey
Take this survey powered by surveymonkey.com. Create your own surveys for free.
000
Jon Salmanton-García @salmantongarcia.bsky.social · 09/02/2026
🧫🦠 How accessible are fungal diagnostics in Australia and New Zealand? This survey reveals strengths, gaps, and delays driven by centralised testing, highlighting urgent needs in β-D-glucan access and resistance surveillance 👉 www.sciencedirect.com/science/arti...
011
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 06/02/2026
At PRISMA Congress, @salmantongarcia.bsky.social presents "The evolving challenge of fungal resistance", highlighting the latest developments and emerging clinical challenges in antifungal resistance. #PRISMA2026 #FungalResistance
023
Jon Salmanton-García @salmantongarcia.bsky.social · 06/02/2026
Always cool to be in #Lisbon, and always important to speak about #antimicrobial_resistances. Thanks to @InêsLeonorLeitão and @CarlosPalos
010
Jon Salmanton-García @salmantongarcia.bsky.social · 26/01/2026
Invasive #Candidiasis in Contexts of Armed Conflict, High #Violence, and Forced #Displacement in #Latin_America and the Caribbean (2005–2025) www.mdpi.com/2309-608X/11...
001
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 23/01/2026
Join the EFISG webinar “Women in Science – Past, Present, and Future” 🧬 📅 11 Feb 2026 | 🕕 18:00 CET 🎓 Inspiring speakers & discussions on women’s careers in science. 👉 Register: us06web.zoom.us/webinar/regi... @salmantongarcia.bsky.social #EFISG_FREE_WEBINAR
033
Jon Salmanton-García @salmantongarcia.bsky.social · 23/01/2026
When will feedback on LMIC studies be truly constructive? Care is done with what’s available, not from an EU/US ivory tower where guidelines are easy to follow Does judging help more than proposing? Sometimes reality ≠ guidelines And yes, this is for you, reviewer #2
000
Jon Salmanton-García @salmantongarcia.bsky.social · 22/01/2026
@efisg-escmid.bsky.social webinar! 11 February - 18.00 CET Registration: us06web.zoom.us/webinar/regi...
002
Reposted by Jon Salmanton-García
ESCMID Fungal Infection Study Group (EFISG) @efisg-escmid.bsky.social · 14/01/2026
#EFISG webinars January - April 2026 More info: www.escmid.org/efisg @escmid.bsky.social @taescmid.bsky.social
001
Jon Salmanton-García @salmantongarcia.bsky.social · 16/01/2026
📢 Survey on PID training 🇪🇺 Residents/junior specialists with PID focus—your input matters www.surveymonkey.com/r/FNW5GWV Missing input from 🇮🇸Iceland 🇽🇰Kosovo 🇱🇻Latvia 🇱🇮Liechtenstein 🇱🇹Lithuania 🇲🇪Montenegro 🇳🇱Netherlands 🇲🇰North_Macedonia Help disseminate 🙏🙏 @escmid.bsky.social @taescmid.bsky.social
000
Jon Salmanton-García @salmantongarcia.bsky.social · 07/01/2026
🦠 Call for Papers: Fungal Infections @BioMedCentral Immunology invites submissions for our Collection on fungal pathogenesis & host immune responses. 📅 Deadline: 26 June 2026 🔗 link.springer.com/collections/... #Immunology #Mycology #FungalInfections #CallForPapers
link.springer.com
Fungal infections
Fungal infections significantly threaten human health, particularly in immunocompromised individuals. The spectrum of fungal infections ranges from ...
011
Jon Salmanton-García @salmantongarcia.bsky.social · 07/01/2026
🦠🌎 #Paracoccidioidomycosis remains a neglected tropical mycosis in #LatinAmerica. This review highlights 21st-century milestones and ongoing challenges in epidemiology, diagnosis, treatment, and social impact—calling for stronger surveillance and collaboration. 📚✨
030
Reposted by Jon Salmanton-García
ESCMID Fungal Infection Study Group (EFISG) @efisg-escmid.bsky.social · 05/01/2026
Nomination phase for EFISG Board ('26–'28) open from 06-01 to 02-02. Each candidate requires support from two EFISG members. To nominate: my.escmid.org → SG elections → EFISG → Support members Good luck to all candidates!
001
Reposted by Jon Salmanton-García
Oliver Cornely @olivercornely.bsky.social · 19/12/2025
Proud to see our article “Respiratory Viruses in Patients with Haematological Malignancy (EPICOVIDEHA-EPIFLUEHA)” surpass 4,000 views. Grateful to all collaborators-turning knowledge into impact. 🔗 onlinelibrary.wiley.com/doi/full/10.... #ViewsMilestone #Hematology @salmantongarcia.bsky.social
onlinelibrary.wiley.com
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA‐EPIFLUEHA Report
Community-acquired respiratory viral infections (CARV) significantly impact patients with hematological malignancies (HM), leading to high morbidity and mortality. However, large-scale, real-world da....
054
Jon Salmanton-García @salmantongarcia.bsky.social · 01/01/2026
📢🇩🇪 E-PEC multicentre study sheds light on MSI/MMR testing in endometrial cancer — real-world patterns for better patient stratification! 🔬🧬 👇https://www.mdpi.com/2075-4418/16/1/100
010
Jon Salmanton-García @salmantongarcia.bsky.social · 15/12/2025
Had an amazing time at the #AEM XII Mycological Forum in #València! Great science, inspiring discussions, and fantastic energy from early-career researchers. Huge thanks to the organizers for the kind invitation — truly a great forum to be part of 🍄✨
010